Cargando…
Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis
INTRODUCTION: Patients with atopic dermatitis (AD) experience burdensome symptoms and impaired quality of life (QoL). The objective of this study was to investigate the effects of topical AD therapies on disease control, physician and patient treatment satisfaction, and QoL in a real-world setting....
Autores principales: | Anderson, Peter, Austin, Jenny, Lofland, Jennifer H., Piercy, James, Joish, Vijay N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484432/ https://www.ncbi.nlm.nih.gov/pubmed/34268709 http://dx.doi.org/10.1007/s13555-021-00580-2 |
Ejemplares similares
-
Extent and Impact of Inadequate Disease Control in US Adults with a History of Moderate to Severe Atopic Dermatitis Following Introduction of New Treatments
por: Vilsbøll, Andreas Westh, et al.
Publicado: (2021) -
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
por: Bloudek, Lisa, et al.
Publicado: (2022) -
Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis
por: Wei, Wenhui, et al.
Publicado: (2017) -
Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan
por: Wang, Chaochen, et al.
Publicado: (2022) -
From the Cochrane Library: Topical Tacrolimus for Atopic Dermatitis
por: Hamp, Austin, et al.
Publicado: (2021)